June is nationally recognized as Pride Month. We're highlighting stories surrounding the LGBTQ community and its impacts on the Susquehanna Valley.

The Centers for Disease Control and Prevention is the latest agency in the Health and Human Services Department to rehire ...

Gilead’s HIV treatment trials involving an investigational integrase strand inhibitor (GS-1720) and an investigational capsid inhibitor (GS-4182) have been put on clinical hold by the Food and Drug ...

People with HIV may experience homelessness when they’re shunned by their families or asked to leave their homes, one ...

The U.S. Food and Drug Administration has paused Gilead Sciences' trials testing a combination of two of its experimental HIV ...

The medication, Lenacapavir, is said to have shown exceptional promise in clinical trials, and some of the research is being conducted here in Houston.

A new injection to prevent HIV is expected to be approved by the US Food and Drug Administration later this month.

People living with HIV have a significantly increased risk of cardiovascular disease that requires a different level of ...

Too bad the Centers for Medicare and Medicaid Services decided on Friday not to broadly cover new anti-obesity medications. For the moment, at least, the Trump administration has missed a chance to ...

Klausner suggested that cuts to HIV prevention would hamper community outreach efforts, which, for example, may lead to vulnerable populations not accessing preventive PrEP medications. This could ...

Ward was hopeful at the start of this year, however, as testing became more widespread and HIV prevention drugs — called preexposure prophylaxis, or PrEP — slowly gained popularity. But her outlook ...